Sign in
Taking peopleNo phase

Eye tracking to study eye movement in thyroid eye disease

Uses eye tracking to compare eye movements in thyroid-associated ophthalmopathy and healthy adults.

Key facts

Who runs it
Shanghai Changzheng Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy
Status
Recruiting
People taking part
100 people, planned
Started
31 Jan 2026
Expected to end
May 2029
Type of study
Observational, 2 groups
Treatments tested
  • Non-invasive Eye Tracking Assessment
Record updated
6 February 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Aged between 18 and 70 years, inclusive
  • Willing and able to provide written informed consent
  • Best-corrected visual acuity (BCVA) ≥ 1.0 in both eyes, with no history of ocular diseases or thyroid disorders

Who cannot take part

  • Prior Ocular Surgery: History of surgeries affecting extraocular muscle mechanics (e.g., strabismus surgery, scleral buckling)
  • Medication Interference: Use of drugs affecting reaction time (e.g., sedatives) within 48 hours of testing
  • Non-TAO Ocular Motility Disorders: History of conditions like myasthenia gravis, cranial nerve palsy, or congenital strabismus
  • Neurological Diseases: Disorders affecting oculomotor control (e.g., Parkinson's, MS, stroke, or brain tumors)
  • Significant Visual Impairment: BCVA < 0.5 due to media opacities or retinopathy, preventing clear visualization of stimuli
  • Psychiatric or Cognitive Disorders: Inability to follow instructions or conditions affecting eye movements (e.g., schizophrenia)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study focuses on eye health and visual function in patients with Thyroid-Associated Ophthalmopathy (TAO), a condition that often causes bulging eyes and restricted eye movement. The purpose of this study is to use non-invasive eye-tracking technology to evaluate how the disease affects eye movement function. The investigators hypothesize that compared to healthy individuals, patients with TAO will show measurable differences in eye stability and the ability to track moving objects. Additionally, the investigators believe the disease may alter how patients visually scan faces (e.g., avoiding eye contact). The study will enroll 100 participants, including both patients and healthy volunteers. By recording gaze patterns while participants look at a screen, the investigators aim to objectively quantify the physical and social impact of the disease, providing better data for future treatment plans.

The 2 groups in the trial

  • TAO

    Treatment: Non-invasive Eye Tracking Assessment

  • CON

    Treatment: Non-invasive Eye Tracking Assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy
Plain-language title
Eye tracking to study eye movement in thyroid eye diseaseGenerated from the registry record. The registry title is the official one.
Fit questions
Built from NCT07381413, who can take part
Publications
Record updated
6 February 2026